ATH 0.00% 0.3¢ alterity therapeutics limited

pbt news, page-17

  1. 597 Posts.
    The root cause of the problem is so well known PBT forgot to tackle it. Which means if I am five years behind the times where does that leave PBT?

    for your guide gravel, there is an existing drug in development (I can't remember what it is called - I'd have to refer to my notes at home) that is showing some promise for those with the dud gene... however it is causing problems for those who have normal age related AD...

    Struth! then maybe they aren't the same disease. Just similar symptoms.

    and that is why PBT2 is so promising

    Because it doesn't actually tackle AD. Instead it tackles AD like symptoms.

    But don't tell the suckers that otherwise we won't get paid our ridiculous out of this earth, lets me afford private school fees pay check next month. Just throw them a line about some big deal in the pipeline.
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.3¢
Change
0.000(0.00%)
Mkt cap ! $15.96M
Open High Low Value Volume
0.3¢ 0.3¢ 0.3¢ $11.43K 3.81M

Buyers (Bids)

No. Vol. Price($)
75 108441696 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 3179951 2
View Market Depth
Last trade - 10.36am 07/11/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.